Skip to content

Clinical trials

Observational Lung Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Observational Country / region: Germany Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20051
20062
20093
20101
20112
20122
20132
20145
20164
20171
20181
20191
20233
20253
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Recruiting8
Unknown status7
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Hospital, Essen5
AstraZeneca4
Amgen2
Intuitive Surgical2
Medical University of Vienna2
Bristol-Myers Squibb1
Broncus Technologies1
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest1
Johnny Moons1
Lung Clinic Hemer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms34
Breast Neoplasms7
Carcinoma, Non-Small-Cell Lung6
Ovarian Neoplasms6
Neoplasms5
Colorectal Neoplasms4
Pancreatic Neoplasms4
Urinary Bladder Neoplasms4
Prostatic Neoplasms3
Carcinoma2

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.